These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6770287)

  • 21. Effect of lead on hepatic delta-aminolaevulinic acid synthetase activity in the rat: a model for drug sensitivity in intermittent acute porphyria.
    Maxwell JD; Meyer UA
    Eur J Clin Invest; 1976 Sep; 6(5):373-9. PubMed ID: 976299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment.
    Magnussen CR; Doherty JM; Hess RA; Tschudy DP
    Neurology; 1975 Dec; 25(12):121-5. PubMed ID: 812008
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of hematin in the acute attack of the "inducible" hepatic prophyrias.
    Watson CJ; Pierach CA; Bossenmaier I; Cardinal R
    Adv Intern Med; 1978; 23():265-86. PubMed ID: 343541
    [No Abstract]   [Full Text] [Related]  

  • 24. Pathogenesis of neural manifestations in acute porphyria.
    Shanley BC; Percy VA; Neethling AC
    S Afr Med J; 1977 Apr; 51(14):458-60. PubMed ID: 870989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of sodium valproate on haem biosynthesis in man: implications for seizure management in the porphyric patient.
    McGuire GM; Macphee GJ; Thompson GG; Moore MR; Brodie MJ
    Eur J Clin Invest; 1988 Feb; 18(1):29-32. PubMed ID: 3130256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antipyrine metabolism in acute hepatic porphyria in relapse and remission.
    Birnie GG; McColl KE; Thompson GG; Moore MR; Goldberg A; Brodie MJ
    Br J Clin Pharmacol; 1987 Mar; 23(3):358-61. PubMed ID: 3567053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hepatic porphyrias.
    Romeo G
    Prog Med Genet; 1980; 4():169-97. PubMed ID: 7003654
    [No Abstract]   [Full Text] [Related]  

  • 28. Experimental hepatic porphyria induced by polychlorinated biphenyls.
    Goldstein JA; Hickman P; Jue DL
    Toxicol Appl Pharmacol; 1974 Feb; 27(2):437-48. PubMed ID: 4211999
    [No Abstract]   [Full Text] [Related]  

  • 29. Anesthesia and the porphyrias.
    Mees DE; Frederickson EL
    South Med J; 1975 Jan; 68(1):29-32. PubMed ID: 1154054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endocrine-gene interaction in the pathogenesis of acute intermittent porphyria.
    Kappas A; Sassa S; Granick S; Bradlow HL
    Res Publ Assoc Res Nerv Ment Dis; 1974; 53():225-37. PubMed ID: 4612660
    [No Abstract]   [Full Text] [Related]  

  • 31. Concomitant use of clonazepam and valproic acid in treatment of epileptic seizures.
    Hildebrandt WK
    Am J Hosp Pharm; 1979 Jan; 36(1):22, 27. PubMed ID: 364980
    [No Abstract]   [Full Text] [Related]  

  • 32. The anticonvulsant effect of sodium valproate and clonazepam in the management of intractable epilepsy.
    Lance JW; Anthony M
    Trans Am Neurol Assoc; 1976; 101():200-4. PubMed ID: 800689
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute intermittent porphyria--another approach to therapy.
    Wider de Xifra EA; Batlle AM; Stella AM; Malamud S
    Int J Biochem; 1980; 12(5-6):819-22. PubMed ID: 7450138
    [No Abstract]   [Full Text] [Related]  

  • 34. [Intermittent acute porphyria. Hepatic ultrastructural study].
    Gaultier M; Gervais P; Bescol J; Conso F; Aubry P; Guillam C
    Ann Med Interne (Paris); 1974; 125(6-7):539-46. PubMed ID: 4440969
    [No Abstract]   [Full Text] [Related]  

  • 35. Sn-protoporphyrin suppresses chemically induced experimental hepatic porphyria. Potential clinical implications.
    Galbraith RA; Drummond GS; Kappas A
    J Clin Invest; 1985 Dec; 76(6):2436-9. PubMed ID: 4077989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of valproate in porphyria cutanea tarda.
    D'Alessandro R; Rocchi E; Cristina E; Cassanelli M; Benassi G; Pizzino D; Baldrati A; Baruzzi A
    Epilepsia; 1988; 29(2):159-62. PubMed ID: 3127197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hereditary hepatic porphyrias.
    Meyer UA; Schmid R
    Fed Proc; 1973 Jun; 32(6):1649-55. PubMed ID: 4710876
    [No Abstract]   [Full Text] [Related]  

  • 38. Functional independence in post-anoxic myoclonus: contribution of L-5-HTP sodium valproate and clonazepam.
    Carroll WM; Walsh PJ
    Br Med J; 1978 Dec; 2(6152):1612. PubMed ID: 365292
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hematin treatment of acute intermittent porphyria. A case report (author's transl)].
    Marchiori PE; de Assis JL; Scaff M; Do Serro-Azul LG; Moraes EC; Bacheschi LA; Yassuda N
    Rev Bras Pesqui Med Biol; 1979 Sep; 12(4-5):325-33. PubMed ID: 531276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of clonazepam and valproate on kainate-induced model of psychomotor seizures.
    Velísek L; Ortová M; Velísková J; Kubová H; Mares P
    Act Nerv Super (Praha); 1989 Apr; 31(1):66-7. PubMed ID: 2506726
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.